<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04739709</url>
  </required_header>
  <id_info>
    <org_study_id>CPN-301</org_study_id>
    <nct_id>NCT04739709</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery</brief_title>
  <official_title>A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Formosa Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Formosa Pharmaceuticals, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Phase 3 study will evaluate APP13007 in comparison to the matching vehicle placebo in a&#xD;
      randomized, parallel-group, double-masked fashion. The subjects will have undergone routine&#xD;
      cataract surgery on Day 0 of the study and will be assessed the next day (Post-operative Day&#xD;
      1; POD1) after uncomplicated surgery for eligibility for randomization to study treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 11, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy as Assessed by Anterior Chamber Cell (ACC) Count</measure>
    <time_frame>Postoperative Day (POD) 8 through POD 15</time_frame>
    <description>Proportion of subjects with ACC count = 0 (0 = 0 ACC, 2 = 1-5 ACC, 3 = 6-15 ACC, 4 = 16-30 ACC, 5 = &gt;30 ACC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy as Assessed by Ocular Pain Grade</measure>
    <time_frame>Postoperative Day (POD) 4 through POD 15</time_frame>
    <description>Proportion of subjects with Ocular Pain Grade = 0 (0 = no pain; 4 = severe pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety as Assessed by Adverse Events (AEs)</measure>
    <time_frame>Screening through Postoperative Day 22</time_frame>
    <description>Incidence of ocular and systemic AEs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety as Assessed by Best Corrected Visual Acuity (BCVA), Slit-lamp Biomicroscopy, and Dilated Indirect Ophthalmoscopy</measure>
    <time_frame>Screening through Postoperative Day 22</time_frame>
    <description>Change from baseline in ocular signs to each post-surgery visit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety as Assessed by Intraocular Pressure (IOP)</measure>
    <time_frame>Screening through Postoperative Day 22</time_frame>
    <description>Change from baseline in IOP using the Goldman applanation tonometer to each visit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Anterior Chamber Cell (ACC) Count</measure>
    <time_frame>Through Postoperative Day 15</time_frame>
    <description>Proportion of subjects with ACC count = 0 (0 = 0 ACC, 2 = 1-5 ACC, 3 = 6-15 ACC, 4 = 16-30 ACC, 5 = &gt;30 ACC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Ocular Pain Grade</measure>
    <time_frame>Through Postoperative Day 15</time_frame>
    <description>Proportion of subjects with Ocular Pain Grade = 0 (0 = no pain; 4 = severe pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Anterior Chamber Flare (ACF)</measure>
    <time_frame>Through Postoperative Day 15</time_frame>
    <description>Proportion of subjects with ACF Grade = 0 (0 = none; 4 = intense)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Anterior Chamber Flare (ACF)</measure>
    <time_frame>Postoperative Day (POD) 8 through POD 15</time_frame>
    <description>Proportion of subjects with ACF Grade = 0 (0 = none; 4 = Intense)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Anterior Chamber Cell (ACC) Count</measure>
    <time_frame>Through Postoperative Day 15</time_frame>
    <description>Mean change in baseline in ACC Grade. Measurement of ACC grade using a slit lamp biomicroscope and a 5 point grading scale (0 = 0 ACC, 2 = 1-5 ACC, 3 = 6-15 ACC, 4 = 16-30 ACC, 5 = &gt;30 ACC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Ocular Pain Grade</measure>
    <time_frame>Through Postoperative Day 15</time_frame>
    <description>Mean change in baseline in Ocular Pain Grade. Measurement of Ocular Pain Grade using a slit lamp biomicroscope and a 5 point grading scale (0 = no pain; 4 = severe pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Anterior Chamber Flare (ACF)</measure>
    <time_frame>Through Postoperative Day 15</time_frame>
    <description>Mean change in baseline in ACF Grade. Measurement of ACF using a slit lamp biomicroscope and a 5 point rating scale (0 = none; 4 = intense)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy as Assessed by Number of Subjects Rescued</measure>
    <time_frame>Postoperative Day (POD) 1 through POD 22</time_frame>
    <description>Number of subjects rescued on or prior to each visit and overall</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">370</enrollment>
  <condition>Ocular Inflammation and Pain</condition>
  <arm_group>
    <arm_group_label>APP13007 0.05% BID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 drop APP13007 0.05% twice daily for 14 days to study (operated) eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Matching Vehicle Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 drop matching vehicle place twice daily for 14 days to study (operated) eye</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>APP13007, 0.05%</intervention_name>
    <description>APP13007 eye drop, 0.05%</description>
    <arm_group_label>APP13007 0.05% BID</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Matching Vehicle Placebo for APP13007, 0.05%</intervention_name>
    <description>Matching vehicle placebo eye drop</description>
    <arm_group_label>Matching Vehicle Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years of age or older expected to undergo unilateral uncomplicated&#xD;
             cataract extraction via phacoemulsification and posterior chamber intraocular lens&#xD;
             implantation in one eye.&#xD;
&#xD;
          -  Have a pin-hole corrected visual acuity without other correction of â‰¤ 1.3 logarithm of&#xD;
             the minimum angle of resolution (logMAR) in the study eye to be operated and&#xD;
             contralateral eye as measured using an Early Treatment Diabetic Retinopathy Study&#xD;
             (ETDRS) chart at Visit 1.&#xD;
&#xD;
          -  Willing and able to comply with study requirements and visit schedule.&#xD;
&#xD;
          -  Provide signed and dated informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have a known sensitivity or allergy to clobetasol propionate, corticosteroids, or any&#xD;
             of the study medication's components including benzalkonium chloride and soybean&#xD;
             lecithin or any routine medication required during cataract surgery or for the conduct&#xD;
             of study procedures&#xD;
&#xD;
          -  Have an ACC count &gt; 0 or any evidence of intraocular inflammation (e.g., flare) in&#xD;
             either eye at the Screening visit&#xD;
&#xD;
          -  Have a Grade &gt; 0 on the Ocular Pain Assessment in either eye at the Screening visit&#xD;
&#xD;
        Note: Other inclusion/exclusion criteria apply.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Ops Representative</last_name>
    <phone>919-797-1146</phone>
    <email>clin.ops@aimmaxrx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Schwartz Laser Eye Center</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Global Research Management</name>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <zip>91204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inland Eye Specialists</name>
      <address>
        <city>Hemet</city>
        <state>California</state>
        <zip>92545</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SoCal Eye Physicians and Associates</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Valley Eye Medical Group, Inc.</name>
      <address>
        <city>Mission Hills</city>
        <state>California</state>
        <zip>91345</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>LoBue Laser and Eye Medical Center, Inc.</name>
      <address>
        <city>Murrieta</city>
        <state>California</state>
        <zip>92562</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pendleton Eye Center</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Martel Eye Medical Group</name>
      <address>
        <city>Rancho Cordova</city>
        <state>California</state>
        <zip>95670</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shasta Eye Medical Group, Inc.</name>
      <address>
        <city>Redding</city>
        <state>California</state>
        <zip>96001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icon Eye Care</name>
      <address>
        <city>Grand Junction</city>
        <state>Colorado</state>
        <zip>81501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Levenson Eye Associates</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>International Eye Associates, PA</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <zip>32174</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newsom Eye and Laser Center</name>
      <address>
        <city>Sebring</city>
        <state>Florida</state>
        <zip>33870</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coastal Research Associates, LLC</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jacksonsye, S.C.</name>
      <address>
        <city>Lake Villa</city>
        <state>Illinois</state>
        <zip>60046</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Midwest Cornea Associates, LLC</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Senior Health Services</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Silverstein Eye Centers, PC</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ophthalmology Consultants, Ltd.</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Comprehensive Eye Care, Ltd.</name>
      <address>
        <city>Washington</city>
        <state>Missouri</state>
        <zip>63090</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>NV Eye Surgery</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center For Sight</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89145</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Raymond Fong, MD, PC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carolina Eye Associates</name>
      <address>
        <city>Southern Pines</city>
        <state>North Carolina</state>
        <zip>28387</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eye Physicians, LLC</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Eye Physicians, LLC</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bucci Laser Vision Institute</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Keystone Research Ltd.</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Retina Research Center, PLLC</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78750</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Houston Eye Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Laser Vision and Surgical Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lake Travis Eye and Laser Center</name>
      <address>
        <city>Lakeway</city>
        <state>Texas</state>
        <zip>78738</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>R and R Eye Research, LLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Antonio Eye Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78238</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stacy R. Smith, MD, PC</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Oftalmologico Metropolitano</name>
      <address>
        <city>San Juan</city>
        <zip>00921</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>February 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Capsule Opacification</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

